Evidence map›Paper›PMID 37649634›Full record

ArticleFrontiers in microbiology2023

Identification of sucrose synthase from

Kai Chen, Lei Lin, Ruiqi Ma, Jiajie Ding, Huayi Pan, Yehui Tao, Yan Li, Honghua Jia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kai Chen *College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Lei Lin *College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Ruiqi MaCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Jiajie DingCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Huayi PanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Yehui TaoCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Yan LiCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Honghua JiaCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Nanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sucrose synthase (SuSy, EC 2.4.1.13) is a unique glycosyltransferase (GT) for developing cost-effective glycosylation processes. Up to now, some SuSys derived from plants and bacteria have been used to recycle uridine 5'-diphosphate glucose in the reactions catalyzed by Leloir GTs. In this study, after sequence mining and experimental verification, a SuSy from

Indexed as

biotransformationglycosylationglycosyltransferaseMicractinium conductrixrebaudioside Msucrose synthase

Identifiers

PMID37649634
PMCPMC10465243
OpenAlexW4385852635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.